Literature DB >> 628812

Renal osmol clearance during prolonged heavy exercise.

H E Refsum, S B Strømme.   

Abstract

Serum and urine osmolality and creatinine were measured in fifty-eight well-trained men, aged 21-57 years, in connection with three 70 km cross-country ski races taking place under essentially the same external circumstances, leading to slight dehydration. Although the race urine flow was low, 0.51 (0.05-1.10) ml/min, the urine osmolality and the urine to serum osmolality ratio were relatively low, averaging 860 (399-1220) mosm/kg H2O and 2.84 (1.32-4.10), respectively. Decreasing urine flow and endogenou- creatinine clearance were associated with decreasing urine to serum osmolality ratio, indicating declining urine concentrating ability. Thus, the data confirm the author's recent suggestion, based on the measurement of a limited number of urine solutes, that during prolonged heavy exercise a decrease in urine flow and glomerular filtration rate is accompanied by a decline in the urine concentrating ability.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628812     DOI: 10.3109/00365517809108397

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

1.  The effect of triathlon on urinary excretion of enzymes and proteins.

Authors:  H Yaguchi; M Ishigooka; S Hayami; T Kobayashi; Y Kubota; T Nakada; K Mitobe
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise.

Authors:  Tamara Hew-Butler; Jed Hummel; Brian C Rider; Joseph G Verbalis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-18       Impact factor: 3.619

3.  Effect of the volume of fluid ingested on urine concentrating ability during prolonged heavy exercise in a hot environment.

Authors:  Hidenori Otani; Mitsuharu Kaya; Junzo Tsujita
Journal:  J Sports Sci Med       Date:  2013-03-01       Impact factor: 2.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.